Research progress on bleeding risk assessment models in anticoagulant therapy

Balancing thromboembolic prevention against bleeding complications remains a critical challenge in anticoagulant therapy. While established bleeding risk assessment models (RAMs) such as HAS-BLED and HEMORR2HAGES were initially developed for warfarin-treated patients, their applicability to non-vita...

Descripción completa

Detalles Bibliográficos

Autores principales:	Li Sen, Xiong Kangpin, Liu Yihui
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-11-01
Colección:	Frontiers in Cardiovascular Medicine
Materias:	anticoagulant therapy bleeding risk assessment models atrial fibrillation venous thromboembolism non-vitamin K antagonist oral anticoagulants
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1645823/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!